Viewing Study NCT02142868


Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2026-02-26 @ 12:37 AM
Study NCT ID: NCT02142868
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2018-12-21
First Post: 2014-05-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module